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Abstract
Background: Patients routinely undergo transesophageal echocardiography (TEE) prior to 
pulmonary vein isolation (PVI) in order to rule out the presence of intra-atrial thrombi. Cardi-
ac computed tomography (CCT) is also routinely conducted prior to the procedure to determine 
cardiac anatomy. Although it has been demonstrated that CCT can also rule out intra-atrial 
thrombi, the use of CCT for thrombi detection is controversial. The primary objective was to 
determine the utility of CCT for detection of atrial thrombi as compared to TEE.
Methods: Patients who underwent PVI between 2010 and 2011 with CTs and TEEs complet-
ed within 3 days of each other were retrospectively identified. TEE reports were analyzed, while 
CCTs were interpreted by a cardiologist specializing in CCTs. Severe spontaneous echo contrast 
or thrombus detected on TEE were considered positive, as were filling defects found on CCT.
Results: A total of 51 patients undergoing PVI (mean age 59.4 ± 9.5 years; 75% male; ejec- 
tion fraction 60 ± 12%) had both TEE and CCT in timely fashion. By TEE, 0 left atrial ap-
pendage (LAA) thrombi were identified with mild to moderate spontaneous echo contrast in  
4 patients. By CCT, 2 definite LAA thrombi were identified and thrombi in 4 patients could not 
be ruled out. Specificity, positive predictive value, and negative predictive value for CCT were 
88%, 0%, and 100%, respectively.
Conclusions: CCT is an effective tool in ruling out atrial thrombi prior to PVI. TEE should 
be completed only if CCT is positive. (Cardiol J 2015; 22, 5: 576–582)
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Introduction
Atrial fibrillation (AF) is a common arrhythmia 
and carries a considerable degree of morbidity [1]. 
AF causes a predisposition to thrombosis within 
the left atrium (LA) and left atrial appendage (LAA) 
due to blood stasis, and increases the long-term 
risk of ischemic stroke secondary to a cardioembol-
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ic events [2]. Therefore, patients are administered 
anticoagulants, depending on their risk of stroke 
as assessed by the CHADS2 score [1, 2].
Current standard of care for patients undergo-
ing pulmonary vein isolation (PVI) [3], a common 
treatment of AF, involves two imaging tests [4]. 
Transesophageal echocardiography (TEE) imaging 
is required to rule out the presence of intracardiac 
thrombus prior to PVI [5]. Cardiac computed to-
mography (CCT) imaging is also required for proce-
dural mapping. Although it has been demonstrated 
that CCT can also effectively rule out intracardiac 
thrombi [6], studies are small and results have 
been inconsistent in findings and methodology 
[5, 7–14]. For instance, the largest study on the subject 
by Martinez et al. [9], reached the conclusion that 
CCT is sensitive enough to warrant the use of only 
CCT to rule out atrial thrombi, but this conclusion 
has been called into question for sub-optimal study 
methodology [15]. Variations in prospective and 
retrospective electrocardiogram (ECG-gating), 
patient positioning, and length of time between 
CCT and TEE are factors that have been inconsist-
ent across studies. As a result of this controversy, 
patients continue to undergo both TEE and CCT 
procedures prior to PVI.
The aim of this study is to determine the 
diagnostic accuracy of CCT compared to TEE in 
excluding LA or LAA thrombi prior to PVI.
Methods
Study population
Consecutive patients selected for PVI by the 
Arrhythmia Service of Kingston General Hospital, 
Ontario, Canada between 2010 and 2011 were in-
cluded in this study. This included both outpatient 
and inpatient subjects who underwent both TEE 
and CCT prior to PVI. Exclusion criteria included 
any patients who did not have TEE and CCT within 
3 days of each other. The study protocol was ap-
proved by the Health Sciences Research Ethics 
Board at Queen’s University, Kingston, Ontario.
TEE technical details
TEE images were acquired in accordance with 
standard patient preparation, using both GE (E9, 
Fairfield, Connecticut) and Philips (iE33, Ando-
ver, Massachusetts) equipment, by cardiologists 
experienced in TEE. LA and LAA imaging were 
performed with 2-dimensional (2D) and occasion-
ally 3D X-plane imaging using a 3.5–7 MHz mul-
tiplane probe. All interpreting cardiologists were 
blinded to patient clinical data. Careful visualization 
of the LA and LAA in multiple views resulted in 
a report stating thrombi seen or thrombi not seen. 
A thrombus was defined as abnormal echogenic 
material within the intracavitary space. No con-
trast agents were used to enhance visualization. If 
present, spontaneous echocardiographic contrast 
(SEC) was commented on. No comment implied 
the absence of SEC.
CCT technical details
CCT was performed with prospective ECG-
-gating and contrast enhancement with a 64-slice 
CT scanner, Toshiba (Aquillon One, Irvine, CA). 
Patients were pretreated with beta-blocker and 
nitroglycerin spray. CT parameters were set at 
gantry rotation time of 330 ms, and a tube voltage of 
100 kVp. Following multiple breath hold exercises, 
an 80 mL bolus of iodinated contrast media (Om-
nipaque 350 [GE Healthcare, Milwaukee, Wiscon-
sin] was injected intravenously) at 5 mL/s. Bolus 
tracking was initiated with the administration of 
80 cc of contrast. Images were obtained every 2 s 
at the level of the descending aorta to monitor 
for appearance of contrast. Contrast appearance 
was defined as 140 Houndsfield Units (HU) in the 
descending aorta. Once contrast was visualized, 
a breath hold instruction was given and the scan 
was initiated. Image acquisition was completed 
with a single breath hold with the patient in the 
supine position. The entire heart was imaged in 
one heartbeat. Due to the CT scanner technology 
of one beat acquisition, delayed scanning and prone 
imaging, would require a second full acquisition. 
Therefore, delayed scanning and prone position-
ing, though they might have increased specificity 
[16], were not completed in order to limit radiation 
exposure to the patient.
Reconstructions were performed with a small 
180 to 240 mm field of view centered on the heart 
with a 0.5 mm slice thickness. Images were re-
constructed into 2D axial, coronal and sagittal 
slices. Multiplanar reconstruction and 3D volume 
rendered images were also generated and reviewed 
when required. No attempt was made to optimize 
imaging of the LAA. All images available were 
reviewed by a CCT trained, Level III certified, 
cardiologist (RSP) who was blind to TEE results, 
on a Vitrea Origin (Vital Enterprises, Minnetonka, 
Minnesota) workstation.
Data collection
Two authors (SM and JC), blind to CCT results, 
retrieved data from the patient record. Data includ-
ed age, gender, body surface area, valvular disease, 
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prior ischemic disease, type and duration of AF or 
atrial flutter, and antiplatelet or anticoagulation 
therapy. Heart rate, blood pressure, creatinine and 
international normalized ratio at the time of the 
procedure were also recorded. The presence of 
contributors to the CHADS2 score was recorded, 
and the CHADS2 score was calculated. TEE re-
ports were reviewed, from which the absence 
or presence of LA/LAA thrombus was extracted. 
Presence or absence of SEC was noted rather than 
grades of mild, moderate or severe SEC, given that 
the latter does not have a quantitative definition. 
Positive thrombi and presence of SEC were both 
considered true positives by TEE. CCT images 
were interpreted by a cardiologist trained in CCT 
(RSP), who was blind to the TEE results. Presence 
of thrombi was noted as “definite”, “cannot rule 
out”, or “absent”. “Definite” thrombus by CT was 
defined as incomplete opacification of the LAA with 
contrast media. “Cannot rule out” thrombus was 
defined as incomplete mixing of contrast material 
in the LAA. “Absent” thrombus was defined as 
complete opacification of the LAA. Both “definite” 
and “cannot rule out” findings were considered 
abnormal CCTs. Radiation doses, HU in the LAA, 
and physical dimensions of the LA and LAA were 
also recorded.
Statistical analysis
Primary outcome measures were thrombi 
detected by TEE and thrombi detected by CCT. 
Demographic data was presented as proportions 
with standard deviations. Quantitative data was 
presented as means with standard deviations. Sen-
sitivity, specificity, negative predictive value (NPV) 
and positive predictive value (PPV) were calculated 
for CCT with TEE results as criterion standard.
Results
A total of 77 patients underwent PVI preceded 
by CCT and TEE between 2010 and 2011. Only 51 
had both imaging tests, TEE and CCT, within 72 h 
of each other, therefore 26 patients were excluded 
from the analysis. Demographic and risk factor data 
can be seen in Table 1. Overall, the 51 subjects had 
Table 1. Clinical characteristics of the patients.
Overall  
(n = 51)
CCT positive  
(n = 6)
Mild to moderate SEC  
(n = 4)
Age [years] 59.4 ± 9.5 59.3 ± 4.8 56.3 ± 8.8
Male 38 (75%) 6 (100%) 4 (100%)
Body surface area [m2] 2.1 ± 0.27 2.2 ± 0.19 2.2 ± 0.27
Duration of atrial fibrillation or flutter [years] 5.0 ± 6.0 2.5 ± 1.4 2.8 ± 1.7
Atrial fibrillation:
Persistent 15 (29%) 5 (83%) 2 (50%)
Paroxysmal 39 (76%) 2 (33%) 2 (50%)
Atrial flutter 7 (14%) 1 (17%) 1 (25%)
Anticoagulation therapy 28 (55%) 6 (100%) 3 (75%)
Antiplatelet therapy 14 (27%) 3 (50%) 1 (25%)
No anticoagulation or antiplatelet therapy 14 (27%) 0 (0%) 1 (25%)
International normalized ratio 1.5 ± 0.6 2.2 ± 0.6 1.4 ± 0.3
Cardiac heart failure 2 (4%) 0 (0%) 0 (0%)
Hypertension 20 (39%) 3 (50%) 0 (0%)
Age ≥ 75 years 2 (4%) 0 (0%) 0 (0%)
Diabetes mellitus 4 (8%) 0 (0%) 1 (25%)
Prior CVA/TIA 2 (4%) 0 (0%) 0 (0%)
CHADS2 score:
0 25 (49%) 3 (50%) 3 (75%)
1 23 (45%) 3 (50%) 1 (25%)
2 0 (0%) 0 (0%) 0 (0%)
3 3 (6%) 0 (0%) 0 (0%)
CCT — cardiac computed tomography; CVA — cerebro-vascular accident; SEC — spontaneous echocardiography contrast; TIA — transient 
ischemic attack
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an average age of 59.4 years, 75% male, 100% with 
AF and 14% with concomitant atrial flutter, 94% 
with CHADS2 score ≤ 1. CCT positive patients 
were more likely than TEE positive and overall 
patients to have persistent AF (83%, 50%, and 29%, 
respectively). Patients with definite and possible 
thrombi by CCT were also more likely to be chroni-
cally anticoagulated than TEE positive and overall 
patients (100%, 75%, 55%, respectively). CHADS2 
scores were not significantly different between the 
overall subject population and the patients with 
positive CCT or TEE findings. Anticoagulation and 
antiplatelet rates represent chronic prophylaxis as 
all patients received warfarin anticoagulation for 
4 weeks prior and following PVI. For TEE, only 
definite thrombi or severe SEC were considered 
true positive, since management decisions were 
not impacted by mild to moderate spontaneous 
echo contrast. No true thrombi were identified by 
TEE. No severe SEC was reported on TEE. Mild 
and moderate SEC was reported in 4 patients in 
total (Table 2). For CCT, both definite and possible 
thrombi were considered positive results. Two defi-
nite thrombi were identified by CCT. In addition, 
there were 4 CCT scans in which thrombus could 
not be ruled out. By TEE, SEC positive patients had 
larger LA volumes (37.2 mm2 vs. 31.4 mm2), but not 
greatly different diameters (42.4 mm vs. 39.9 mm). 
Positive thrombi by CCT also had greater LA volumes 
compared to negative tests (56.3 mm vs. 42.3 mm). 
It should be noted that 30% of TEE reports and 
8% of CCT reports did not document LA volu-
mes and thus were not included in our analysis. 
Of the 4 patients with mild or moderate SEC by 
TEE, only 1 had definite or possible thrombi by 
CCT. Conversely, of the 6 patients with definite 
or possible thrombi by CCT, none had associated 
with thrombi or SEC by TEE and were therefore 
all false positives. Overall, CCT had a specificity 
of 88%, PPV of 0%, and NPV of 100%. As there 
were no positive thrombi by TEE, sensitivity for 
CCT could not be calculated.
Discussion
Both TEE and CCT have advantages and 
disadvantages. CCT is rapid and non-invasive. 
However, it requires contrast administration and 
radiation exposure to the patient [7]. TEE is ac-
curate and easily accessible. However, it is invasive 
and is associated with a small risk of esophageal 
rupture. It also requires sedation due to patient 
discomfort [17].
Current literature includes both prospective 
and retrospective cross-sectional studies, and 
a meta-analysis [5, 7–13, 18]. Study sizes have 
varied from 72 to 402 patients [7, 9], yet current 
literature remains controversial. Martinez et al. 
[9] found sensitivity and specificity of CCT to be 
100% and 92%, respectively concluding that TEE 
is unnecessary. Similarly, Hur et al. [13] found 
a sensitivity and specificity of 89% and 100%. In 
contrast, Tang et al. [10] conclude from CCT sensi-
tivity and specificity of 36.4% and 93.7% that both 
modalities are necessary. Variation in results can 
partially be explained by inconsistency in CCT and 
TEE methodology. Garcia [15] criticized Martinez 
et al. [9] for suboptimal methodology in adminis-
tration of contrast, possibly affecting visualization. 
The clinical impact of prospective and retrospective 
ECG-gating on CCT results has also been called 
into question [10], as have variations in patient 
positioning during CCT [19]. Lastly, the length of 
time between CCT and TEE has varied, as Mar-
tinez et al. ensured CCT and TEE were conducted 
within 24 h, whereas Kim et al. allowed a gap of up 
to one week [5, 9, 13].
The results of this study demonstrate that 
in a population of patients with AF, CCT has high 
specificity for detecting absence of LAA thrombus 
(Fig. 1). Furthermore, CCT has 100% NPV. How-
ever, when CCT is positive, thrombus is at times 
not visualized on TEE, suggesting that it cannot 
be used to predict the presence of thrombus. Our 
findings do not support the routine use of both CCT 
and TEE prior to PVI. Rather, they suggest that 
CCT is ideal as the first and only test in patients 
Table 2. Findings by transesophageal echocardio-
graphy prior to pulmonary vein isolation.
LAA thrombus 0 (0%)
Spontaneous echo contrast: 4 (8%)
Mild 2
Moderate 2
Severe 0
Ejection fraction [%] 59.5 ± 12.2
LA volume [mm2]: 31.9 ± 8.5
SEC positive (mild,  
moderate or severe)
37.2 ± 8.9 
SEC negative 31.4 ± 8.6 
LA diameter [mm]: 40.1 ± 7.2
SEC positive (mild,  
moderate or severe)
42.4 ± 9.4 
SEC negative 39.9 ± 7.1 
LAA — left atrial appendage; LA — left atrium; SEC — spontaneous 
echocardiographic contrast
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prior to PVI, with TEE reserved for CCT positive 
patients. Reduction from two imaging modalities 
to one would result in significant cost reductions 
as well as having positive implications for patient 
safety and comfort. Given the occurrence of false 
positives in CCT, TEE will still need to be em-
ployed to rule out intracardiac thrombi in all cases 
with possible thrombi by CCT.
The presence of thrombi in patients undergo-
ing PVI is low, reported as 1.2% by Michael et 
al. [20]. A more recent study by Hong et al. [21] 
demonstrated that periprocedural incidence of LAA 
thrombus identification and stroke is low, further 
supporting that patients can be screened by CCT 
alone. None of the patients in our study undergo-
ing PVI was found to have a definite thrombus 
identified by TEE. This may be related to the low 
CHADS2 score of the majority of this study popu-
lation (94%). However, given the low incidence 
of thrombus formation in the overall PVI patient 
population, these findings could be generalizable 
to higher CHADS2 risk patients as well. Notably, 
all SEC and CCT positive results did not have 
a CHADS2 scores ≥ 2.
Mild to moderate SEC on TEE was not a pre-
dictor of a false positive CCT. Only 1 of 4 patients 
with mild to moderate SEC on TEE had a false 
positive result on CCT. Also, the other 5 false 
positive CCT findings did not correspond to any 
SEC on TEE. Hence, false positive results on CCT 
rarely corresponded to mild to moderate SEC on 
TEE. The 2 cases reported as “definite” thrombus 
on CCT, but were negative on TEE, had unique 
structural characteristics. One patient had a dihe-
dral LAA, with one head demonstrating decreased 
contrast density. This may have been due to incom-
plete mixing of contrast in CCT or due to incom-
plete visualization of both heads by TEE (Fig. 2A). 
The other patient had a severely enlarged LA and 
Figure 2. A. Incomplete opacification of the left atrial appendage (LAA) due to a possible dihedral structure of the LAA 
(gray arrows); B. Another cardiac computed tomography identifying a “definite” thrombus within the LAA (gray arrow), 
but negative by transesophageal echocardiography. The LAA is severely enlarged leading to incomplete opacification.
Figure 1. Normal cardiac computed tomography with 
no left atrial appendage clots.
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LAA. The LAA had decreasing contrast density in 
the more distal aspect of the appendage. Again, this 
may have been secondary to incomplete contrast 
mixing on CCT or incomplete visualization by TEE 
(Fig. 2B). Interestingly, both SEC positive and 
CCT positive tests were associated with larger 
LA volumes compared to the normal tests. These 
positive results were likely due to the ineffective 
contractions secondary to the large LA volumes. 
These results also suggest that LA size may be 
the most optimal way to define patients requiring 
both tests.
Our results are in agreement with Martinez et 
al. [9], the largest study in this subject area, who re-
ported a specificity of 92% and a NPV of 100%. This 
study also drew the conclusion that TEE may be 
eliminated from routine practice. We hypothesize 
that our results are similar to Martinez et al. [9] 
because it is the most recent study, reflecting the 
evolution of CCT technology and technique over 
time. With increasing standardization of technol-
ogy, we anticipate our results to be reproducible.
Similarly, the meta-analysis by Romero et al. 
[18], which included 19 studies for a total of 2,955 
patients, demonstrated a sensitivity and specific-
ity of 96% and 92%. The PPV and NPV of CCT 
were 41% and 99%, respectively. Performing 
a sub-analysis by limiting the studies to those 
with delayed imaging increased the sensitivity and 
specificity to 100% and 99%, respectively, yielding 
a PPV and NPV of 92% and 100%. However, the 
study by Romero et al. [18] suffered from varying 
results in assessment of publication bias, based 
on the test used. Finally, a large study by Hong et 
al. [21] further supports the low incidence of both 
LAA thrombus and stroke periprocedural to PVI.
Limitations of the study
Our study is limited by its small sample size, 
which when compounded with a low rate of atrial 
thrombi by CCT or TEE, prevents detailed statis-
tical analysis. Delayed scanning, which increases 
specificity of CCT by decreasing detection of 
pseudothrombi, was not routinely completed at 
our center.
Conclusions
CCT presents high specificity and NPV for 
detection of atrial thrombi. TEE should be used 
to rule out thrombi only in patients with positive 
CCT results or severely enlarged LA size.
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